4483N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Strong Profitability And MarginsSustained high gross and operating margins indicate durable unit economics for JMDC’s data and analytics services. Strong margins support reinvestment in data assets, cushion cyclical revenue swings, and enable long-term profitability even if top-line growth slows.
Recurring, Data-driven Revenue ModelA business model built on recurring platform access and analytics fees creates predictable revenue streams and customer stickiness. This recurring structure supports stable long-term cash flows, higher lifetime customer value, and scalable margins as data assets expand.
Proprietary Data Assets And Industry RelevanceControl of large, standardized medical datasets provides JMDC with durable competitive advantages: barriers to entry, strong product-market fit with insurers and pharma, and ongoing demand for real-world evidence and risk analytics that underpin recurring revenue.
Bears Say
Decelerating Revenue GrowthA marked slowdown to low-single-digit revenue growth reduces leverage from fixed-cost margins and limits the company’s ability to scale earnings rapidly. Persistently slower top-line expansion could pressure future investment returns and make margin maintenance more critical.
Rising Financial LeverageIncreasing debt-to-equity signals greater reliance on external financing, which can constrain strategic flexibility and raise interest and refinancing risks. Higher leverage reduces the buffer for cash-flow volatility and may limit capital allocation options over the medium term.
Volatile Cash GenerationInconsistent operating and free cash flow—including a negative year and a subsequent rebound—reduces confidence in cash conversion. This variability complicates planning for R&D, data acquisition, dividends, or debt servicing and raises execution risk over 2–6 months.
4483N FAQ
What was JMDC Inc.’s price range in the past 12 months?
Currently, no data Available
What is JMDC Inc.’s market cap?
JMDC Inc.’s market cap is $22.35B.
When is JMDC Inc.’s upcoming earnings report date?
JMDC Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 10 days.
How were JMDC Inc.’s earnings last quarter?
JMDC Inc. released its earnings results on May 08, 2026. The company reported $3.193 earnings per share for the quarter, missing the consensus estimate of $3.84 by -$0.647.
Is JMDC Inc. overvalued?
According to Wall Street analysts JMDC Inc.’s price is currently Undervalued.
Does JMDC Inc. pay dividends?
JMDC Inc. does not currently pay dividends.
What is JMDC Inc.’s EPS estimate?
JMDC Inc.’s EPS estimate is 0.97.
How many shares outstanding does JMDC Inc. have?
JMDC Inc. has 65,446,205 shares outstanding.
What happened to JMDC Inc.’s price movement after its last earnings report?
JMDC Inc. reported an EPS of $3.193 in its last earnings report, missing expectations of $3.84. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of JMDC Inc.?
Currently, no hedge funds are holding shares in MX:4483N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JMDC Inc.
JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.